Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$411K Hold
1,134
0.1% 187
2026
Q1
$399K Sell
1,134
-40
-3% -$14.3K 0.11% 182
2025
Q4
$384K Sell
1,174
-3
-0.3% -$952 0.11% 179
2025
Q3
$332K Sell
1,177
-6
-0.5% -$1.74K 0.1% 190
2025
Q2
$330K Sell
1,183
-122
-9% -$34.6K 0.1% 186
2025
Q1
$407K Buy
1,305
+156
+14% +$46.1K 0.14% 154
2024
Q4
$299K Buy
1,149
+61
+6% +$18.1K 0.1% 193
2024
Q3
$351K Buy
+1,088
New +$356K 0.12% 176

Other funds holding AMGN

White Pine Capital's AMGN Position: Q2 2026 in Review

White Pine Capital held its Amgen (AMGN) position steady in Q2 2026 at 1,134 shares worth $411K. The position accounts for 0.1% of the portfolio, ranked #187.

White Pine Capital first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • White Pine Capital held 1,134 shares of Amgen worth $411K as of Q2 2026.
  • White Pine Capital left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.1% of White Pine Capital's portfolio in Q2 2026, its #187 holding.
  • White Pine Capital first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on White Pine Capital's 13F filing for Q2 2026, filed 5 Aug 2026.